Bio-Techne
TECH
#1989
Rank
A$14.54 B
Marketcap
A$93.36
Share price
-2.93%
Change (1 day)
-18.15%
Change (1 year)
Bio-Techne Corporation is an American holding company for biotechnology and clinical diagnostic brands. The company's brands portfolio includes R&D Systems, Novus Biologicals, Tocris Bioscience, ProteinSimple, Exosome Diagnostics, BiosPacific, Cliniqa, Advanced Cell Diagnostics, RNA Medical, Bionostics and BostonBiochem.

EPS for Bio-Techne (TECH)

EPS in 2025 (TTM): A$0.79

According to Bio-Techne's latest financial reports the company's current EPS (TTM) is A$0.76. In 2024 the company made an earnings per share (EPS) of A$1.51 a decrease over its 2023 EPS that were of A$2.15.

EPS history for Bio-Techne from 2014 to 2025

Annual EPS

Year EPS Change
2025 (TTM)A$0.79-47.88%
2024A$1.51-29.58%
2023A$2.15-14.97%
2022A$2.5324.16%
2021A$2.0417.98%
2020A$1.73-10.94%
2019A$1.94101.57%
2018A$0.96-16.99%
2017A$1.1645.02%
2016A$0.80-20.97%
2015A$1.01-14.97%
2014A$1.19

EPS for similar companies or competitors

Company EPS EPS differencediff. Country
Thermo Fisher Scientific
TMO
A$26.25 3,368.00%๐Ÿ‡บ๐Ÿ‡ธ USA
Bio-Rad Laboratories
BIO
A-$36.80-4,962.00%๐Ÿ‡บ๐Ÿ‡ธ USA
Becton Dickinson
BDX
A$8.43 1,014.00%๐Ÿ‡บ๐Ÿ‡ธ USA
Danaher
DHR
A$7.39 876.00%๐Ÿ‡บ๐Ÿ‡ธ USA
Qiagen
QGEN
A$2.83 273.74%๐Ÿ‡ณ๐Ÿ‡ฑ Netherlands
General Electric
GE
A$11.44 1,412.00%๐Ÿ‡บ๐Ÿ‡ธ USA
Enzo Biochem
ENZB
A-$0.32-142.00%๐Ÿ‡บ๐Ÿ‡ธ USA